View More Recent Stories
-
Clorox (CLX) PT Lowered to $165 at Citi
-
After-hours movers: Palantir, NXP Semiconductors, Lumentum and more
-
Clorox (CLX) Tops Q2 EPS by 16c; offers guidance
-
DA Davidson on impact of tariffs on Health & Beauty/ Leisure stocks
-
Barclays Reiterates Underweight Rating on Clorox (CLX)
-
Clorox (CLX) February option implied volatility flat into quarter results
-
Clorox (CLX) February 160 straddle priced into quarter results
-
Clorox (CLX) Announces CFO Change
-
UBS Reiterates Neutral Rating on Clorox (CLX)
-
2025 Staples outlook and Q4 earnings preview
-
This consumer stock is a new 2025 Top Pick at Jefferies
-
Jefferies Reiterates Buy Rating on Clorox (CLX), '2025 Top Pick'
-
Clorox (CLX) Appoints Stephen Bratspies and Pierre Breber to its Board
-
Clorox (CLX) Declares $1.22 Quarterly Dividend; 2.9% Yield
-
TD Cowen Upgrades Clorox (CLX) to Hold
-
Clorox Announces Partnership With M2030 To Advance Supply Chain Climate Action
-
Clorox (CLX) PT Raised to $171 at DA Davidson
-
Clorox (CLX) PT Raised to $188 at Jefferies
-
Clorox (CLX) Tops Q1 EPS by 47c; offers guidance
-
The impact of the presidential election on the U.S. consumer sector
-
Goldman Sachs Reiterates Sell Rating on Clorox (CLX)
-
Jefferies Upgrades Clorox (CLX) to Buy, 'Back to the Future - A Fresh Start'
-
Clorox (CLX) Completes Previously Announced Divestiture of its Better Health VMS Business
-
Clorox (CLX) PT Raised to $140 at Exane BNP Paribas
-
Clorox (CLX) PT Raised to $170 at Citi
-
Clorox (CLX) PT Raised to $174 at Jefferies
-
Clorox (CLX) PT Raised to $165 at Citi
-
Clorox (CLX) Introduces Plant-Based Clorox EcoClean Disinfecting Wipes
-
Clorox (CLX) August 2 weekly 141 puts active
-
Clorox (CLX) PT Lowered to $140 at Evercore ISI
-
Clorox (CLX) PT Raised to $151 at Deutsche Bank
-
Clorox (CLX) PT Raised to $148 at Jefferies
-
Clorox (CLX) Tops Q4 EPS by 27c, Offers Guidance
-
TD Cowen Starts Clorox (CLX) at Sell

